Month: May 2021
-
Trial Underway Testing Cannabis Migraine Treatments
A clinical trial is enrolling participants to test three different types of inhaled cannabis therapies against a placebo to treat migraine.
-
Crispr Treatment Leads to Durable Cholesterol Reduction
A developer of gene editing for inherited heart disease reports lab monkeys given its therapy experience lower cholesterol levels for at least eight months.
-
Small Biz Grant Funds Covid-19 Antiviral Therapy
A biotechnology company developing cancer therapies is receiving an NIH grant to extend its technology for antiviral peptides against the SARS-CoV-2 virus.
-
Gene Therapy Company Starts-Up, Gains $200M
A new company is underway commercializing research on gene therapies for inherited diseases, staked to an initial investment of $200 million.
-
How Data Science Can Help Your Business
Once you have a good handle on the data behind your business, you can move forward, ensuring that you make the right choices and can improve along the way.
-
Trial Shows Same High/Low Dose Aspirin Outcomes
Results from a large-scale clinical trial show almost the same health outcomes for patients prescribed high or low doses of aspirin to prevent heart disease.
-
Infographic – Health Care A.I. Funds Jump in Q1
Venture funding for start-ups providing artificial intelligence services in health care climbed to a record high volume in the first quarter of 2021.
-
Medical Devices to Reduce Military Travel Disorders
Biomedical engineers at university labs are designing medical devices that reduce jet lag and intestinal problems faced by military service members.
-
New Biotech Creating Precision Cancer Therapies
A biotechnology company began work in public to develop new treatments that target proteins responsible for gene expression, beginning with cancer.
-
Early-Stage Life Science Investment Fund Raises $515M
A new venture investment fund raised $515 million for life science start-ups, and its business incubator partner added five biotechs to its seed round portfolio.